Patent · US Active

Coronavirus vaccine

US11878055B1 · kind B1 · utility

2Cited by

103References

30Claims

0Family size

Assignee

BIONTECH SE · DE

Inventors

Alexander Muik · Seeheim-Jugenheim, DE
Kena Anne Swanson · Pearl River, US
Qi Yang · The Woodlands, US
Hui-Zhi Cai · Ridgewood, US
Ugur Sahin · Mainz, DE
Kayvon Modjarrad · Chevy Chase Section Five, US

Key dates

Filing date	Jun 26, 2023
Grant date	Jan 23, 2024
Priority date	—
Expiry date	Jun 26, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/20071
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against coronavirus infection and inducing effective coronavirus antigen-specific immune responses such as antibody and/or T cell responses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.